
NNOX Valuation
Nano-X Imaging Ltd
- Overview
- Forecast
- Valuation
- Earnings
NNOX Relative Valuation
NNOX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NNOX is overvalued; if below, it's undervalued.
Historical Valuation
Nano-X Imaging Ltd (NNOX) is now in the Overvalued zone, suggesting that its current forward PS ratio of 18.82 is considered Overvalued compared with the five-year average of -14.66. The fair price of Nano-X Imaging Ltd (NNOX) is between 3.17 to 4.31 according to relative valuation methord. Compared to the current price of 4.70 USD , Nano-X Imaging Ltd is Overvalued By 8.98%.
Relative Value
Fair Zone
3.17-4.31
Current Price:4.70
8.98%
Overvalued
-6.79
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Nano-X Imaging Ltd. (NNOX) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -6.36. The thresholds are as follows: Strongly Undervalued below -36.59, Undervalued between -36.59 and -21.48, Fairly Valued between 8.75 and -21.48, Overvalued between 8.75 and 23.87, and Strongly Overvalued above 23.87. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-4.71
EV/EBIT
Nano-X Imaging Ltd. (NNOX) has a current EV/EBIT of -4.71. The 5-year average EV/EBIT is -12.25. The thresholds are as follows: Strongly Undervalued below -34.59, Undervalued between -34.59 and -23.42, Fairly Valued between -1.07 and -23.42, Overvalued between -1.07 and 10.10, and Strongly Overvalued above 10.10. The current Forward EV/EBIT of -4.71 falls within the Historic Trend Line -Fairly Valued range.
18.82
PS
Nano-X Imaging Ltd. (NNOX) has a current PS of 18.82. The 5-year average PS is 627.49. The thresholds are as follows: Strongly Undervalued below -2524.56, Undervalued between -2524.56 and -948.54, Fairly Valued between 2203.51 and -948.54, Overvalued between 2203.51 and 3779.54, and Strongly Overvalued above 3779.54. The current Forward PS of 18.82 falls within the Historic Trend Line -Fairly Valued range.
-14.95
P/OCF
Nano-X Imaging Ltd. (NNOX) has a current P/OCF of -14.95. The 5-year average P/OCF is -28.25. The thresholds are as follows: Strongly Undervalued below -72.19, Undervalued between -72.19 and -50.22, Fairly Valued between -6.28 and -50.22, Overvalued between -6.28 and 15.69, and Strongly Overvalued above 15.69. The current Forward P/OCF of -14.95 falls within the Historic Trend Line -Fairly Valued range.
-8.35
P/FCF
Nano-X Imaging Ltd. (NNOX) has a current P/FCF of -8.35. The 5-year average P/FCF is 3.62. The thresholds are as follows: Strongly Undervalued below -93.52, Undervalued between -93.52 and -44.95, Fairly Valued between 52.18 and -44.95, Overvalued between 52.18 and 100.75, and Strongly Overvalued above 100.75. The current Forward P/FCF of -8.35 falls within the Historic Trend Line -Fairly Valued range.
Nano-X Imaging Ltd (NNOX) has a current Price-to-Book (P/B) ratio of 1.76. Compared to its 3-year average P/B ratio of 2.42 , the current P/B ratio is approximately -27.32% higher. Relative to its 5-year average P/B ratio of 4.08, the current P/B ratio is about -56.79% higher. Nano-X Imaging Ltd (NNOX) has a Forward Free Cash Flow (FCF) yield of approximately -13.40%. Compared to its 3-year average FCF yield of -10.83%, the current FCF yield is approximately 23.75% lower. Relative to its 5-year average FCF yield of -8.03% , the current FCF yield is about 66.94% lower.
1.76
P/B
Median3y
2.42
Median5y
4.08
-13.40
FCF Yield
Median3y
-10.83
Median5y
-8.03
Competitors Valuation Multiple
The average P/S ratio for NNOX's competitors is 5.22, providing a benchmark for relative valuation. Nano-X Imaging Ltd Corp (NNOX) exhibits a P/S ratio of 18.82, which is 260.54% above the industry average. Given its robust revenue growth of 10.26%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of NNOX decreased by 26.22% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 2.55M to 2.82M.
The secondary factor is the Margin Expansion, contributed -1.91%to the performance.
Overall, the performance of NNOX in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch

RDVT
Red Violet Inc
43.470
USD
-1.23%

BCAL
California Bancorp
15.250
USD
+1.46%

GHM
Graham Corp
49.080
USD
+4.49%

MGTX
MeiraGTx Holdings PLC
7.950
USD
+2.71%

ALT
Altimmune Inc
3.600
USD
-1.91%

GLRE
Greenlight Capital Re Ltd
13.050
USD
+0.23%

GAIN
Gladstone Investment Corp
14.000
USD
+1.01%

RNAC
Cartesian Therapeutics Inc
11.280
USD
-4.65%
FAQ

Is Nano-X Imaging Ltd (NNOX) currently overvalued or undervalued?
Nano-X Imaging Ltd (NNOX) is now in the Overvalued zone, suggesting that its current forward PS ratio of 18.82 is considered Overvalued compared with the five-year average of -14.66. The fair price of Nano-X Imaging Ltd (NNOX) is between 3.17 to 4.31 according to relative valuation methord. Compared to the current price of 4.70 USD , Nano-X Imaging Ltd is Overvalued By 8.98% .

What is Nano-X Imaging Ltd (NNOX) fair value?

How does NNOX's valuation metrics compare to the industry average?

What is the current P/B ratio for Nano-X Imaging Ltd (NNOX) as of Aug 07 2025?

What is the current FCF Yield for Nano-X Imaging Ltd (NNOX) as of Aug 07 2025?

What is the current Forward P/E ratio for Nano-X Imaging Ltd (NNOX) as of Aug 07 2025?
